Valuation
- Market cap
- 30,466,000
- Revenue TTM
- $0
- Net income TTM
- $-1,280,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- -0.02
Trading
- Volume
- 100
- Avg volume
- —
- Day's range
- $1.51 – $1.51
- Shares out
- 20,176,000
- Stochastic %K
- —
- Beta
- 1.78
- Analysts
- —
- Price target
- —
Company profile
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. Raphael Ph...
Show more
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. Raphael Pharmaceutical Inc., is headquartered in Jaffa, Israel.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 972 5 2775 5072
- Website
- https://www.raphaelpharmaceutical.com
- Address
- 4 Lui Paster, Jaffa, Israel
Latest news
No headlines yet.
